Deflazacort in the treatment of Duchenne dystrophy and other neurological diseases November 10, 2022 News On November 11, 2022, organized by “Realpharma”, a seminar was held: “Deflazacort in the treatment of Duchenne dystrophy and other neurological diseases”. Share: Older Post Calcifediol Treatment and COVID-19–Related Outcomes Newer Post New generation analgesics in pain syndrome pathogenesis and clinical practice